TickerFacts.

Kestra Medical Technologies, Ltd. (KMTS): Capital Expenditures

Annual figures by period end, from SEC filings.

$34.89M
Year ended 2026-04-30
$35.06M
Trailing 12 months to 2026-07-31
2024-04-30: $12.23M2025-04-30: $22.94M2026-04-30: $34.89M$34.89M
2024-04-30 Capital Expenditures (USD) 2026-04-30
Period endedCapital ExpendituresChange YoYSource filing
2026-04-30$34.89M+52.1%2026-07-14, From 2025-05-01
2025-04-30$22.94M+87.6%2026-07-14, From 2024-05-01
2024-04-30$12.23Mn/a2025-07-17, From 2023-05-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Kestra Medical Technologies, Ltd. (KMTS)2026-04-30$34.89M+52.1%
NeuroPace Inc (NPCE)2025-12-31$332.0K+8.5%
Pulmonx Corp (LUNG)2025-12-31$452.0K-68.8%
Beta Bionics, Inc. (BBNX)2025-12-31$5.30M+56.0%
Delcath Systems, Inc. (DCTH)2025-12-31$1.55M+176.7%
Iradimed Corp (IRMD)2025-12-31$7.76M-3.0%
TELA Bio, Inc. (TELA)2025-12-31$448.0K-54.7%
Anika Therapeutics, Inc. (ANIK)2025-12-31$6.83M-11.7%
Orasure Technologies Inc (OSUR)2025-12-31$4.20M+10.5%

Compare KMTS, NPCE, LUNG, BBNX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗